Please login to the form below

Not currently logged in
Email:
Password:

accessibility

This page shows the latest accessibility news and features for those working in and with pharma, biotech and healthcare.

Key emerging trends in digital health

Key emerging trends in digital health

From the ever-increasing availability of new apps aiming to help the management of chronic disease to the increasing popularity of video doctor appointments, digital technologies offer improved accessibility and ease

Latest news

More from news
Approximately 1 fully matching, plus 63 partially matching documents found.

Latest Intelligence

  • How can we realise the benefits of patient engagement? How can we realise the benefits of patient engagement?

    vital; information must be shared in lay terms so all parties can contribute in an informed way; accessibility must be assessed to ensure there are no barriers to participation, and patients

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    data. The importance of real-world data is growing rapidly, but its quality, taxonomy and accessibility are not standardised and once again require collaboration to pull it off.

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    If we can do that, we can help create an open, collaborative and innovative healthcare ecosystem, and increase the accessibility and efficiency of healthcare services in China.”. ... Earlier this year, it unveiled new partnerships with tech giants

  • Creating a successful global compliance programme Creating a successful global compliance programme

    The DOJ reiterated the importance of certain elements and controls, such as the design, accessibility and communication of policies and procedures, providing ‘gatekeepers’ (persons with the authority to issue payments or

  • A catalyst for change A catalyst for change

    China’s plan to boost innovation and improve drug accessibility. In the past decade, the unreasonably long drug approval period in China (often up to six or seven years) had been ... The government is now determined to establish an efficient drug

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics